Evidence map›Paper›PMID 31253111›Full record

ArticleBMC public health2019

Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain.

Jesús Castro-Marrero, Mónica Faro, María Cleofé Zaragozá, Luisa Aliste, Tomás Fernández de Sevilla, José Alegre

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05454683 (Effect of Melatonin Plus Zinc Supplementation on Fatigue, Pain, Sleep Disturbances, Anxiety and Depression, and Autonomic Dysfunction in ME/CFS), which is not on this map. Cited by 41 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 5 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05454683 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Effect of Melatonin Plus Zinc Supplementation on Fatigue, Pain, Sleep Disturbances, Anxiety and Depression, and Autonomic Dysfunction in ME/CFS: a Randomized, Double-blind, Placebo-controlled Study

TypeinterventionalSponsorLaboratorios Viñas, S.A.Ran2022 to 2024Enrolled106ConditionsChronic Fatigue Syndrome, Myalgic EncephalomyelitisArmsmelatonin plus zinc, isomaltose and magnesium stearate
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 5 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map.Health technology assessment (Winchester, England) · 2025
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Herbal extract (Integrative medicine research · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jesús Castro-MarreroCFS/ME Unit, Vall d'Hebron University Hospital Research Institute, Universitat Autónoma de Barcelona, Passeig de Vall d'Hebron 119-129, E-08035, Barcelona, Spain. jesus.castro@vhir.org.ORCID http://orcid.org/0000-0002-2481-3052
Mónica FaroEAP CAP Terrassa Nord, Consorcio Sanitario de Terrassa, Barcelona, Spain.
María Cleofé ZaragozáCFS/ME Unit, Vall d'Hebron University Hospital Research Institute, Universitat Autónoma de Barcelona, Passeig de Vall d'Hebron 119-129, E-08035, Barcelona, Spain.
Luisa AlisteCFS/ME Unit, Vall d'Hebron University Hospital Research Institute, Universitat Autónoma de Barcelona, Passeig de Vall d'Hebron 119-129, E-08035, Barcelona, Spain.
Tomás Fernández de SevillaCFS/ME Unit, Vall d'Hebron University Hospital Research Institute, Universitat Autónoma de Barcelona, Passeig de Vall d'Hebron 119-129, E-08035, Barcelona, Spain.
José AlegreCFS/ME Unit, Vall d'Hebron University Hospital Research Institute, Universitat Autónoma de Barcelona, Passeig de Vall d'Hebron 119-129, E-08035, Barcelona, Spain.
Universitat Autònoma de Barcelona · ESConsorci Sanitari de Terrassa · ESHebron University · PS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFew reports have examined the association between unemployment and work disability in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). This study explored the key determinants of work disability in a CFS/ME cohort.

methodsA community-based prospective study included 1086 CFS/ME patients aged 18-65 years. Demographic and clinical characteristics and outcome measures were recorded. Multiple linear regression analysis was performed to identify key risk indicators of work disability.

resultsFour hundred and fifty patients with CFS/ME were employed (41.4%) and 636 were unemployed (58.6%). Older age at pain onset (OR: 1.44; 95% CI: 1. 12-1.84, autonomic dysfunction (OR: 2.21; 95% CI: 1.71-2.87), neurological symptom (OR: 1.66; 95% CI: 1. 30-2.13) and higher scores for fatigue (OR: 2.61; 95% CI: 2.01-3.39), pain (OR: 2.09; 95% CI: 1.47-2.97), depression (OR: 1.98; 95% CI: 1. 20-3.26), psychopathology (OR: 1.98; 95% CI: 1.51-2.61) and sleep dysfunction (OR: 1.47; 95% CI: 1. 14-1.90) were all associated with a higher risk of work disability due to illness.

conclusionsUsing an explanatory approach, our findings suggest that unemployment is consistently associated with an increased risk of work disability due to CFS/ME, although further more rigorous research is now needed to help in targeting interventions at the workplace.

Indexed as

AdultCross-Sectional StudiesFatigue Syndrome, ChronicFemaleHumansMaleMiddle AgedPersons with DisabilitiesSpainUnemploymentChronic fatigue syndromeComorbidityMyalgic encephalomyelitisQuality of lifeUnemploymentWork disability

Identifiers

PMID31253111
PMCPMC6599355
OpenAlexW2955330545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.